- Author(s):
- Organization(s):
Aptar Pharma
A brief look at new options
Market opportunities include use of unit-dose and bidose devices and preservative-free formulations while unmet needs include treatment of CNS diseases. Product lifecycle management and nose-to-brain delivery are also discussed.